(Q43722409)

26 November 2017

title

Short- and long-term effect of acetylcholinesterase inhibition on the expression and metabolism of the amyloid precursor protein (English)

1 reference

26 November 2017

1

1 reference

26 November 2017

5

1 reference

26 November 2017

M Sironi

2

1 reference

26 November 2017

A Caprera

series ordinal

3

1 reference

26 November 2017

G König

series ordinal

4

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 September 2001

1 reference

26 November 2017

1 reference

26 November 2017

volume

6

1 reference

26 November 2017

issue

5

1 reference

26 November 2017

page(s)

520-528

1 reference

Amyloid beta-protein and the genetics of Alzheimer's disease

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000878

7 January 2021

Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000878

7 January 2021

The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000878

7 January 2021

Cleavage of amyloid beta peptide during constitutive processing of its precursor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000878

7 January 2021

Exact cleavage site of Alzheimer amyloid precursor in neuronal PC-12 cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000878

7 January 2021

Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000878

7 January 2021

Muscarinic regulation of Alzheimer's disease amyloid precursor protein secretion and amyloid beta-protein production in human neuronal NT2N cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000878

7 January 2021

Cholinesterase inhibitors increase secretion of APPs in rat brain cortex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000878

7 January 2021

Tacrine alters the secretion of the beta-amyloid precursor protein in cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000878

7 January 2021

Metrifonate induces cholinesterase inhibition exclusively via slow release of dichlorvos

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000878

7 January 2021

Defective phorbol ester-stimulated secretion of beta-amyloid precursor protein from Alzheimer's disease fibroblasts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000878

7 January 2021

A new and rapid colorimetric determination of acetylcholinesterase activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000878

7 January 2021

Using neuroblastoma cell lines to address differential specificity to organophosphates

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000878

7 January 2021

Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000878

7 January 2021

Alpha 2-macroglobulin synthesis in interleukin-6-stimulated human neuronal (SH-SY5Y neuroblastoma) cells Potential significance for the processing of Alzheimer β-amyloid precursor protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000878

7 January 2021

An update on primary drug therapies for Alzheimer disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000878

7 January 2021

Is there a rationale for the use of acetylcholinesterase inhibitors in the therapy of Alzheimer's disease?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000878

7 January 2021

Regulated secretion of beta-amyloid precursor protein in rat brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000878

7 January 2021

Metrifonate benefits cognitive, behavioral, and global function in patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000878

7 January 2021

The pharmacological basis for metrifonate's favourable tolerability in the treatment of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000878

7 January 2021

In vitro effects of metrifonate on neuronal amyloid precursor protein processing and protein kinase C level

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000878

7 January 2021

Tyrosine phosphorylation-dependent stimulation of amyloid precursor protein secretion by the m3 muscarinic acetylcholine receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000878

7 January 2021

The secretion of amyloid beta-peptides is inhibited in the tacrine-treated human neuroblastoma cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000878

7 January 2021

Changes in beta amyloid precursor protein secretion associated with the proliferative status of CNS derived progenitor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000878

7 January 2021

Identifiers

DOI

10.1038/SJ.MP.4000878

1 reference

Dimensions Publication ID

26 November 2017

1043166128

0 references

1 reference